TrialHaematologica2010

Voriconazole for secondary prophylaxis of invasive fungal infections in allogeneic stem cell transplant recipients: results of the VOSIFI study.

Catherine Cordonnier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.